[Pneumococcal bacteremia in patients aged over 65 years. A study of 161 cases]

M Vaqueiro Subirats1, M Sampere Valero, B Font Creus

  • 1Médico Adjunto de Medicina Interna. Responsable Clínico del Centro Sociosanitario Albada. Corporació Parc Taulí. Sabadell. Barcelona.

Medicina Clinica
|September 20, 2001
PubMed
Abstract

Insights

Older adults experience higher rates of pneumococcal bacteremia, penicillin resistance, and mortality. Age, nosocomial infection, and pneumonia severity predict mortality in this demographic.

Area of Science:

  • Infectious Diseases
  • Bacteriology
  • Epidemiology

Context:

  • Presents a prospective analysis of pneumococcal bacteremia in adults.
  • Highlights differences in outcomes between patients over 65 and those aged 15-64.
  • Focuses on Streptococcus pneumoniae infections in a clinical setting.

Purpose:

  • To analyze pneumococcal bacteremia in patients over 65 years.
  • To compare clinical characteristics and outcomes with younger patients.
  • To identify mortality predictors in elderly patients with pneumococcal bacteremia.

Summary:

  • A prospective study (1988-1999) analyzed 321 pneumococcal bacteremias in patients over 14 years old.
  • Patients over 65 had higher rates of penicillin resistance (32.5% vs. 21.7%) and mortality (25.3% vs. 11.5%).
  • Key mortality predictors identified were advanced age, nosocomial bacteremia, and multi-lobe pneumonia involvement.

Impact:

  • Demonstrates a significant burden of pneumococcal bacteremia in the elderly population.
  • Underscores the need for targeted prevention and treatment strategies for older adults.
  • Provides critical data for understanding and mitigating mortality risk factors in pneumococcal infections.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...